SARS‑CoV‑2 mutation hotspots incidence in different geographic regions

J. Ahmad, G. Tayib, T. Mohamed
{"title":"SARS‑CoV‑2 mutation hotspots incidence in different geographic regions","authors":"J. Ahmad, G. Tayib, T. Mohamed","doi":"10.21608/mb.2020.46676.1026","DOIUrl":null,"url":null,"abstract":"ABSTRACT SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is RNA virus with a positive-sense single-strand that belongs to the beta-coronavirus group that causes COVID-19 (Coronavirus Disease 2019) which originally emerged in China. Viruses with RNA genomes are known by a high mutation rate potential. The mutation rate determines genome variability and evolution of the virus; therefore, allowing viruses to evade the immune system, gain more infectivity potentials, virulence modifications, and probably resistance development to antivirals. A total of 311 SARS-CoV-2 virus whole genome sequences have been retrieved from the GISAID database from 1st of January 2020 to 31th of August 2020. The sequences were analyzed for sequence purity and multiple sequence alignment together with reference sequence was conducted through using Clustal Omega that is imbedded in Jalview software and Blast tools. We recorded the occurrence of 4 newly incident high frequently occurring mutations in all six geographic regions, namely at positions 2416, 18877, 23401, and 27964. The majority of all recorded hotspots were detected in Asia, Europe, and North America. The findings of our study suggest that the SARS-CoV-2 is in continuous evolution. For the impact of these mutations, further investigations are required and to understand whether these mutations would lead to the appearance of Drug-resistance viral strains, strains with increased infectivity and pathogenicity, and also their effect on the vaccine development and immunogenesis.","PeriodicalId":32201,"journal":{"name":"Microbial Biosystems Journal","volume":"244 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial Biosystems Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/mb.2020.46676.1026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

ABSTRACT SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is RNA virus with a positive-sense single-strand that belongs to the beta-coronavirus group that causes COVID-19 (Coronavirus Disease 2019) which originally emerged in China. Viruses with RNA genomes are known by a high mutation rate potential. The mutation rate determines genome variability and evolution of the virus; therefore, allowing viruses to evade the immune system, gain more infectivity potentials, virulence modifications, and probably resistance development to antivirals. A total of 311 SARS-CoV-2 virus whole genome sequences have been retrieved from the GISAID database from 1st of January 2020 to 31th of August 2020. The sequences were analyzed for sequence purity and multiple sequence alignment together with reference sequence was conducted through using Clustal Omega that is imbedded in Jalview software and Blast tools. We recorded the occurrence of 4 newly incident high frequently occurring mutations in all six geographic regions, namely at positions 2416, 18877, 23401, and 27964. The majority of all recorded hotspots were detected in Asia, Europe, and North America. The findings of our study suggest that the SARS-CoV-2 is in continuous evolution. For the impact of these mutations, further investigations are required and to understand whether these mutations would lead to the appearance of Drug-resistance viral strains, strains with increased infectivity and pathogenicity, and also their effect on the vaccine development and immunogenesis.
SARS - CoV - 2突变热点在不同地理区域的发病率
SARS-CoV-2(严重急性呼吸综合征冠状病毒2)是一种具有正义单链的RNA病毒,属于引起COVID-19(冠状病毒病2019)的β冠状病毒群,最初在中国出现。具有RNA基因组的病毒具有较高的突变率潜力。突变率决定了病毒的基因组变异和进化;因此,允许病毒逃避免疫系统,获得更多的传染性潜力,毒力改变,并可能对抗病毒药物产生耐药性。从2020年1月1日至2020年8月31日的GISAID数据库中检索到311个SARS-CoV-2病毒全基因组序列。利用嵌入在Jalview软件和Blast工具中的Clustal Omega对序列进行纯度分析,并与参考序列进行多序列比对。在所有6个地理区域中,分别在2416、18877、23401和27964位点记录到了4个新发生的高频率突变。在所有记录的热点中,大多数在亚洲、欧洲和北美被发现。我们的研究结果表明,SARS-CoV-2处于持续进化中。对于这些突变的影响,需要进行进一步的调查,以了解这些突变是否会导致耐药病毒株的出现,这些病毒株具有更高的传染性和致病性,以及它们对疫苗开发和免疫发生的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
0.00%
发文量
9
审稿时长
4 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信